These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 12106923)

  • 1. Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia: the Low Density Lipoprotein-Apheresis Coronary Morphology and Reserve Trial (LACMART).
    Matsuzaki M; Hiramori K; Imaizumi T; Kitabatake A; Hishida H; Nomura M; Fujii T; Sakuma I; Fukami K; Honda T; Ogawa H; Yamagishi M
    J Am Coll Cardiol; 2002 Jul; 40(2):220-7. PubMed ID: 12106923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group.
    Mabuchi H; Koizumi J; Shimizu M; Kajinami K; Miyamoto S; Ueda K; Takegoshi T
    Am J Cardiol; 1998 Dec; 82(12):1489-95. PubMed ID: 9874053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intensive lipid lowering by low-density lipoprotein apheresis on regression of coronary atherosclerosis in patients with familial hypercholesterolemia: Japan Low-density Lipoprotein Apheresis Coronary Atherosclerosis Prospective Study (L-CAPS).
    Nishimura S; Sekiguchi M; Kano T; Ishiwata S; Nagasaki F; Nishide T; Okimoto T; Kutsumi Y; Kuwabara Y; Takatsu F; Nishikawa H; Daida H; Yamaguchi H
    Atherosclerosis; 1999 Jun; 144(2):409-17. PubMed ID: 10407502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-density lipoprotein apheresis for prevention and regression of atherosclerosis: clinical results.
    Bambauer R; Olbricht CJ; Schoeppe E
    Ther Apher; 1997 Aug; 1(3):242-8. PubMed ID: 10225746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. The Osaka LDL-Apheresis Multicenter Trial Group.
    Kitabatake A; Sato H; Hori M; Kamada T; Kubori S; Hoki N; Minamino T; Yamada M; Kato T
    Clin Ther; 1994; 16(3):416-28. PubMed ID: 7923308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The retardation of progression, stabilization, and regression of coronary and carotid atherosclerosis by low-density lipoprotein apheresis in patients with familial hypercholesterolemia.
    Koga N
    Ther Apher; 1997 Aug; 1(3):260-70. PubMed ID: 10225750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis.
    Thompson GR; Maher VM; Matthews S; Kitano Y; Neuwirth C; Shortt MB; Davies G; Rees A; Mir A; Prescott RJ
    Lancet; 1995 Apr; 345(8953):811-6. PubMed ID: 7898227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary plaque regression: role of low density lipoprotein-apheresis.
    Barter PJ
    J Am Coll Cardiol; 2002 Jul; 40(2):228-30. PubMed ID: 12106924
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia.
    Richter WO; Donner MG; Höfling B; Schwandt P
    Metabolism; 1998 Jul; 47(7):863-8. PubMed ID: 9667236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-year follow-up of familial hypercholesterolemia patients after intensive cholesterol-lowering therapy.
    Masaki N; Tatami R; Kumamoto T; Izawa A; Shimada Y; Takamatsu T; Katsushika S; Ishise S; Maruyama Y; Yoshimoto N
    Int Heart J; 2005 Sep; 46(5):833-43. PubMed ID: 16272774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries.
    Reijman MD; Tromp TR; Hutten BA; Hovingh GK; Blom DJ; Catapano AL; Cuchel M; Dann EJ; Gallo A; Hudgins LC; Raal FJ; Ray KK; Sadiq F; Soran H; Groothoff JW; Wiegman A; Kusters DM; ;
    Lancet Child Adolesc Health; 2024 Jul; 8(7):491-499. PubMed ID: 38759658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study. The LARS Investigators.
    Tatami R; Inoue N; Itoh H; Kishino B; Koga N; Nakashima Y; Nishide T; Okamura K; Saito Y; Teramoto T
    Atherosclerosis; 1992 Jul; 95(1):1-13. PubMed ID: 1642687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy.
    Hong MK; Lee CW; Kim YH; Park DW; Lee SW; Park CB; Jang JS; Han KH; Cheong SS; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2006 Oct; 98(7):866-70. PubMed ID: 16996864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporation of low-density lipoprotein apheresis into the treatment program of patients with severe hypercholesterolemia.
    Gordon BR
    Curr Atheroscler Rep; 2000 Jul; 2(4):308-13. PubMed ID: 11122759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of LDL apheresis on carotid arterial atherosclerosis in familial hypercholesterolaemic patients.
    Koga N; Watanabe K; Kurashige Y; Sato T; Hiroki T
    J Intern Med; 1999 Jul; 246(1):35-43. PubMed ID: 10447223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiographic and pathological studies on regression of coronary atherosclerosis of FH patients who received LDL-apheresis treatment.
    Koga N; Iwata Y; Yamamoto A
    Artif Organs; 1992 Apr; 16(2):171-6. PubMed ID: 10078240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical application and effectiveness of low-density lipoprotein apheresis in the treatment of coronary artery disease.
    Daida H; Yamaguchi H
    Ther Apher; 1997 Aug; 1(3):253-4. PubMed ID: 10225748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Liposorber Study Group.
    Gordon BR; Kelsey SF; Dau PC; Gotto AM; Graham K; Illingworth DR; Isaacsohn J; Jones PH; Leitman SF; Saal SD; Stein EA; Stern TN; Troendle A; Zwiener RJ
    Am J Cardiol; 1998 Feb; 81(4):407-11. PubMed ID: 9485128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific Lp(a) apheresis: A tool to prove lipoprotein(a) atherogenicity.
    Pokrovsky SN; Afanasieva OI; Safarova MS; Balakhonova TV; Matchin YG; Adamova IYU; Konovalov GA; Ezhov MV
    Atheroscler Suppl; 2017 Nov; 30():166-173. PubMed ID: 29096833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of homozygous familial hypercholesterolemia with low density lipoprotein apheresis: a 4 year follow-up study.
    Fadul JE; Vessby B; Wikström B; Danielson BG
    Artif Organs; 1997 May; 21(5):364-8. PubMed ID: 9129767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.